Patents by Inventor Klaus-Dieter Hungerer

Klaus-Dieter Hungerer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunogenic hybrid protein OprF-Oprl derived from Pseudomonas aeruginosa membrane proteins
    Patent number: 6300102
    Abstract: The present invention relates to a hybrid protein comprising the Pseudomonas aeruginosa outer membrane protein I (OprI) which is fused with its amino terminal end to the carboxy-terminal end of a carboxy-terminal portion of the Pseudomonas aeruginosa outer membrane protein F (OprF), as well as to monoclonal or polyclonal antibodies against this hybrid protein. Both, the hybrid protein and the antibodies directed to the hybrid protein confer protection against an infection by Pseudomonas aeruginosa to laboratory animals or man.
    Type: Grant
    Filed: March 10, 1999
    Date of Patent: October 9, 2001
    Assignee: Chiron Behring GmbH & Co.
    Inventors: Bernhard Knapp, Klaus-Dieter Hungerer, Michael Bröker, Bernd-Ulrich von Specht, Horst Domdey
  • Immunogenic hybrid protein OprF-OprI derived from Pseudomonas aeruginosa membrane proteins
    Patent number: 5955090
    Abstract: The present invention relates to a hybrid protein comprising the Pseudomonas aeruginosa outer membrane protein I (OprI) which is fused with its amino terminal end to the carboxy-terminal end of a carboxy-terminal portion of the Pseudomonas aeruginosa outer membrane protein F (OprF), as well as to monoclonal or polyclonal antibodies against this hybrid protein. Both, the hybrid protein and the antibodies directed to the hybrid protein confer protection against an infection by Pseudomonas aeruginosa to laboratory animals or man.
    Type: Grant
    Filed: December 14, 1995
    Date of Patent: September 21, 1999
    Assignee: Chiron Behring GmbH & Co.
    Inventors: Bernhard Knapp, Klaus-Dieter Hungerer, Michael Broker, Bernd-Ulrich von Specht, Horst Domdey
  • Pharmaceutical which can be administered nasally, a process for its preparation, and its use
    Patent number: 4891226
    Abstract: A pharmaceutical which is for nasal administration and contains a high molecular weight active compound and a gel-forming agent and, where appropriate, auxiliaries is described. High molecular weight active compounds of this type are, in particular, immunogens or other pharmacologically effective substances. In addition, a process for the preparation of a pharmaceutical of this type and its use are described.
    Type: Grant
    Filed: December 14, 1988
    Date of Patent: January 2, 1990
    Assignee: Behringwerke Aktiengesellschaft
    Inventors: Klaus-Dieter Bremecker, Klaus-Dieter Hungerer, Hansjorg Ronneberger
  • Substance having immunological activity and process for its manufacture
    Patent number: 4024242
    Abstract: Method of chemically attenuating trypanosomes with a phenanthridine compound, such as 3,8-diamino-5-ethyl-6-phenyl phenanthridine, to obtain non-pathogenic organisms with immunological activity; attenuated organisms produced in this way; vaccines containing such attenuated organisms.
    Type: Grant
    Filed: June 23, 1975
    Date of Patent: May 17, 1977
    Assignee: Hoechst Aktiengesellschaft
    Inventor: Klaus-Dieter Hungerer